We've heard for one year now the problems with the non-harmonization of regulations in other countries with those in Canada. I'm sure it's something you're aware of—being able to use pharmaceuticals in the United States that you can't use here, creating a competitive advantage for them. Are you experiencing the same thing, and would you be recommending changes? If so, what kinds of changes do you think should be made?
On April 27th, 2010. See this statement in context.